These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
299 related articles for article (PubMed ID: 22001794)
1. Inclusion complexes of isoflavones with two commercially available dendrimers: Solubility, stability, structures, release behaviors, cytotoxicity, and anti-oxidant activities. Zhao C; Wang Y; Su Y; Zhang H; Ding L; Yan X; Zhao D; Shao N; Ye X; Cheng Y Int J Pharm; 2011 Dec; 421(2):301-9. PubMed ID: 22001794 [TBL] [Abstract][Full Text] [Related]
2. Comparison of generation 3 polyamidoamine dendrimer and generation 4 polypropylenimine dendrimer on drug loading, complex structure, release behavior, and cytotoxicity. Shao N; Su Y; Hu J; Zhang J; Zhang H; Cheng Y Int J Nanomedicine; 2011; 6():3361-72. PubMed ID: 22267921 [TBL] [Abstract][Full Text] [Related]
3. Polypropyleneimine and polyamidoamine dendrimer mediated enhanced solubilization of bortezomib: Comparison and evaluation of mechanistic aspects by thermodynamics and molecular simulations. Chaudhary S; Gothwal A; Khan I; Srivastava S; Malik R; Gupta U Mater Sci Eng C Mater Biol Appl; 2017 Mar; 72():611-619. PubMed ID: 28024628 [TBL] [Abstract][Full Text] [Related]
4. Poly(amidoamine) and poly(propyleneimine) dendrimers show distinct binding behaviors with sodium dodecyl sulfate: insights from SAXS and NMR analysis. Li T; Shao N; Liu Y; Hu J; Wang Y; Zhang L; Wang H; Chen D; Cheng Y J Phys Chem B; 2014 Mar; 118(11):3074-84. PubMed ID: 24606033 [TBL] [Abstract][Full Text] [Related]
5. Ligand anchored dendrimers based nanoconstructs for effective targeting to cancer cells. Gupta U; Dwivedi SK; Bid HK; Konwar R; Jain NK Int J Pharm; 2010 Jun; 393(1-2):185-96. PubMed ID: 20382210 [TBL] [Abstract][Full Text] [Related]
6. Drug delivery investigations of quaternised poly(propylene imine) dendrimer using nimesulide as a model drug. Murugan E; Geetha Rani DP; Yogaraj V Colloids Surf B Biointerfaces; 2014 Feb; 114():121-9. PubMed ID: 24184533 [TBL] [Abstract][Full Text] [Related]
7. Influence of different generations of poly(propylene imine) dendrimers on human erythrocytes. Mishra V; Gupta U; Jain NK Pharmazie; 2010 Dec; 65(12):891-5. PubMed ID: 21284258 [TBL] [Abstract][Full Text] [Related]
8. Investigations on biodistribution of technetium-99m-labeled carbohydrate-coated poly(propylene imine) dendrimers. Agashe HB; Babbar AK; Jain S; Sharma RK; Mishra AK; Asthana A; Garg M; Dutta T; Jain NK Nanomedicine; 2007 Jun; 3(2):120-7. PubMed ID: 17572354 [TBL] [Abstract][Full Text] [Related]
9. A comparative study on solubility improvement of tetracycline and dexamethasone by poly(propylene imine) and polyamidoamine dendrimers: An insight into cytotoxicity and cell proliferation. Najafi F; Salami-Kalajahi M; Roghani-Mamaqani H; Kahaie-Khosrowshahi A J Biomed Mater Res A; 2020 Mar; 108(3):485-495. PubMed ID: 31682311 [TBL] [Abstract][Full Text] [Related]
10. Reducing cytotoxicity while improving anti-cancer drug loading capacity of polypropylenimine dendrimers by surface acetylation. Wang F; Cai X; Su Y; Hu J; Wu Q; Zhang H; Xiao J; Cheng Y Acta Biomater; 2012 Dec; 8(12):4304-13. PubMed ID: 22842039 [TBL] [Abstract][Full Text] [Related]
11. Understanding the binding interactions between dendrimer and 18 common amino acids by NMR techniques. Wang M; Gong X; Hu J; Yu Y; Chen Q; Cheng Y J Phys Chem B; 2011 Nov; 115(44):12728-35. PubMed ID: 21932783 [TBL] [Abstract][Full Text] [Related]
12. Performance evaluation of PAMAM dendrimer based simvastatin formulations. Kulhari H; Pooja D; Prajapati SK; Chauhan AS Int J Pharm; 2011 Feb; 405(1-2):203-9. PubMed ID: 21145960 [TBL] [Abstract][Full Text] [Related]
13. Synthesis of a folate functionalized PEGylated poly(propylene imine) dendrimer as prospective targeted drug delivery system. Sideratou Z; Kontoyianni C; Drossopoulou GI; Paleos CM Bioorg Med Chem Lett; 2010 Nov; 20(22):6513-7. PubMed ID: 20888223 [TBL] [Abstract][Full Text] [Related]
14. Evaluation of anionic half generation 3.5-6.5 poly(amidoamine) dendrimers as delivery vehicles for the active component of the anticancer drug cisplatin. Kirkpatrick GJ; Plumb JA; Sutcliffe OB; Flint DJ; Wheate NJ J Inorg Biochem; 2011 Sep; 105(9):1115-22. PubMed ID: 21704583 [TBL] [Abstract][Full Text] [Related]
15. The influence of maltose modified poly(propylene imine) dendrimers on hen egg white lysozyme structure and thermal stability. Ciolkowski M; PaĆecz B; Appelhans D; Voit B; Klajnert B; Bryszewska M Colloids Surf B Biointerfaces; 2012 Jun; 95():103-8. PubMed ID: 22410344 [TBL] [Abstract][Full Text] [Related]
16. Gene delivery efficiency and cytotoxicity of heterocyclic amine-modified PAMAM and PPI dendrimers. Hashemi M; Tabatabai SM; Parhiz H; Milanizadeh S; Amel Farzad S; Abnous K; Ramezani M Mater Sci Eng C Mater Biol Appl; 2016 Apr; 61():791-800. PubMed ID: 26838910 [TBL] [Abstract][Full Text] [Related]
17. Poly (amidoamine) dendrimer-mediated hybrid formulation for combination therapy of ramipril and hydrochlorothiazide. Singh MK; Pooja D; Kulhari H; Jain SK; Sistla R; Chauhan AS Eur J Pharm Sci; 2017 Jan; 96():84-92. PubMed ID: 27614111 [TBL] [Abstract][Full Text] [Related]
18. Aqueous poly(amidoamine) dendrimer G3 and G4 generations with several interior cores at pHs 5 and 7: a molecular dynamics simulation study. Kavyani S; Amjad-Iranagh S; Modarress H J Phys Chem B; 2014 Mar; 118(12):3257-66. PubMed ID: 24588382 [TBL] [Abstract][Full Text] [Related]
20. Evaluation of polyamidoamine (PAMAM) dendrimers as drug carriers of anti-bacterial drugs using sulfamethoxazole (SMZ) as a model drug. Ma M; Cheng Y; Xu Z; Xu P; Qu H; Fang Y; Xu T; Wen L Eur J Med Chem; 2007 Jan; 42(1):93-8. PubMed ID: 17095123 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]